NanoString Technologies, Inc. has announced that it has signed a multi-year, multi-investigator research collaboration with Harvard-affiliated Brigham and Women’s Hospital to accelerate the ...

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced plans to commercially unveil the CosMx™ Spatial ...

NanoString Technologies (NSTG) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.64 per share a year ago. These ...

Wednesday, 10x Genomics Inc TXG won an injunction in its patent litigation against NanoString Technologies Inc NSTG and its German subsidiary regarding CosMx Spatial Molecular Imager instruments. The ...

Inclusion of Abcam validated antibodies in CosMx curated protein panel provides the first high-plex spatial multiomic solution at single-cell and subcellular resolution SEATTLE & CAMBRIDGE, United ...

NanoString Technologies, Inc. and Cell Signaling Technology have reached an agreement to use highly validated antibodies from CST in NanoString's 3D BiologyTM Protein Profiling Panels. 3D Biology ...

NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Seattle-based publicly traded biotech company NanoString Technologies said in ...

NanoString Technologies (NSTG) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.69 per share a year ago. These ...

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today the commercial unveiling of its new AtoMx™ Spatial ...

Bruker (NASDAQ:BRKR) will buy NanoString Technologies, a Seattle-based innovator in gene expression profiling and spatial transcriptomics for ~$392.6M in cash, and the assumption of certain ...